NeuroOne Medical Technologies Corporation (NMTC)
- Previous Close
0.8490 - Open
0.8600 - Bid 0.7884 x 100
- Ask 0.8565 x 100
- Day's Range
0.8016 - 0.8759 - 52 Week Range
0.8016 - 2.0000 - Volume
181,048 - Avg. Volume
194,047 - Market Cap (intraday)
23.092M - Beta (5Y Monthly) 0.98
- PE Ratio (TTM)
-- - EPS (TTM)
-0.5800 - Earnings Date Aug 12, 2024 - Aug 16, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.15
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
www.n1mtc.comRecent News: NMTC
Performance Overview: NMTC
Trailing total returns as of 6/7/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NMTC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NMTC
Valuation Measures
Market Cap
23.09M
Enterprise Value
20.78M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.99
Price/Book (mrq)
5.99
Enterprise Value/Revenue
5.58
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-128.49%
Return on Equity (ttm)
-272.79%
Revenue (ttm)
3.73M
Net Income Avi to Common (ttm)
-12.8M
Diluted EPS (ttm)
-0.5800
Balance Sheet and Cash Flow
Total Cash (mrq)
2.43M
Total Debt/Equity (mrq)
3.16%
Levered Free Cash Flow (ttm)
-7.44M